跳至主要内容
临床试验/NCT05371392
NCT05371392尚未招募不适用

Polymorphism of the ITGA4 Gene (Integrin Subunit Alpha 4) in Chronic Lymphocytic Leukemia

Sohag University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
试验地点
1
主要终点
ITGA4 gene expression pattern in chronic lymphocytic leukemia

研究概览

简要总结

Chronic lymphocytic leukemia (CLL) is a clonal lymphoproliferative disorder that is characterized by heterogeneous presentation at the clinical and molecular levels. ITGA4 protein has been found to be deregulated in CLL with adverse clinical outcome. ITGA4 gene (CD49d) encodes a member of the integrin alpha chain family of proteins and is considered a negative prognosticator in CLL with aggressive course and short time to treatment.

The aim of the study:

is to investigate ITGA4 gene expression pattern in CLL.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者
是

入选标准

  • •Patients with newly diagnosed CLL.

排除标准

  • •▪ Patients previously diagnosed as CLL and received treatment before.
  • •Patients with other solid tumors.

结局指标

主要结局

ITGA4 gene expression pattern in chronic lymphocytic leukemia

时间窗: 1 year following the startpoint of the study

Detection of ITGA4 gene expression in blood samples in patients with chronic lymphocytic leukemia, Briefly, total RNA and genomic DNA extraction from fresh peripheral blood samples by Real-time -RT-polymerase chain reaction system (RT-PCR) will be carried out. Rate of ITGA4 gene expression will be recorded.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amer Ahmed Youssef Abdalkareem

Specialist of clinical and chemical pathology

Sohag University

研究点 (1)

Loading locations...

相似试验